Community Fundraising Wrap Up Jan-Mar 2021
15 April 2021
It's been a while since we last recognised the generous support of our amazing community fundraisers. The easing of COVID-19 restrictions has seen the return of some of our annual events and the start of the running event season. We are extremely grateful to our community fundraisers who continue to support us in these challenging times so we can move closer to our goal of zero deaths from melanoma.
Our first annual event to return this year was the Erik Mather 2, 4, 6 Swim hosted by the Balmoral Beach Club. A huge thank you to the entire club and Monika Mather for raising over $50,000 to support MIA’s Erik Mather PhD Scholarship program. Despite the rain, the conditions were perfect for ocean swimming and even MIA’s CEO Matthew Browne, Medical Directors Prof Georgina Long AO and Prof Richard Scolyer, and Prof Anne Cust donned their wetsuits and joined the swim. Congrats to all involved for another successful event!
Last year a much-loved member of the Cockburn Cricket Club Ladies Team was diagnosed with Stage IV melanoma. So, on 20 February the Cockburn Cricket Club held a Ladies' Day with plenty of food, games, and prizes, plus guest speakers - Andrew Kamphaug, from MIA WA and Paige McNeil from the MIA Speakers’ Hub. Thank you to Amanda Rowe and all those who attended to help raise $6,750 for vital life-saving research.
A massive thanks to 'Team Just Keep Swimming' (shown at top from left to right: Tania, Tammie, Anna and Kiara), and solo swimmer Flavia (shown at bottom, second from left, with her support crew) for their incredible efforts during the South32 Rottnest Channel Swim in March. Despite gruelling conditions in the water, the swimmers raised a combined total of $8,510, what an incredible result!
On 28 March, RunWest in Western Sydney was the first event to kick off the running season. We had 26 people representing Team Melanoma who collectively raised $1,140! A big thanks to all who participated and a special shout out to our top three fundraisers: Tara Kairouz, Lisa Duclos,and Sharon Hewitt.
Deb Guion sadly lost her husband, Omri Godijn, to melanoma shortly after his 46th birthday earlier this year. Deb believes MIA's research was instrumental in extending Omri's life by at least 18 months. Deb chose to set up a fundraising page in memory of Omri to support MIA's ongoing research in the hope of changing the outcomes for all future melanoma patients. An enormous thank you to Deb and all your friends and family for raising over $14,000.
We are so thankful for the generous support from all our community fundraisers. Your efforts don't go unnoticed and everything you do helps us move closer to our goal of zero deaths from melanoma, a goal our Co-Medical Directors believe we can reach this decade.
Using MIA's patient database, researchers have developed conditional survival estimates for Stage III melanoma patients to more accurately predict survival outcomes.
MIA is proud to be celebrating an important milestone – the 60th anniversary of melanoma research and Australian-led global efforts to find a cure.
Research achievements by MIA were celebrated at the annual Sydney Medical School recently.
In this Global Research Report we showcase advances in medical oncology, reveal unexpected pathology in acral and skin melanoma, and uncover biomarkers and new gene targets for melanoma.
Professor’s Long and Scolyer are well known in the academic community and beloved by their patients. But we wanted to get to know our new Conjoint Medical Directors a little more and hear their plans on making an impact on melanoma.
Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.
Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank.
MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.
Two of the world’s best minds in melanoma have taken over the academic and clinical leadership of Melanoma Institute Australia (MIA). Professor Georgina Long and Professor Richard Scolyer are the new Conjoint Medical Directors of MIA, and are shaping the future direction of melanoma research, treatment and education.
Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.
To celebrate International Women's Day 2017, MIA shares how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
We welcome Mr Grant King to the position of Chairman of the Board of Melanoma Institute Australia, following the retirement of Mr Reg Richardson AM who led the organisation for 10 years.
Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work.
Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.
A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.
Sunscreen tips for a skin smart summer with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.
Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.
Lucinda Ryan and Carole Renouf talking about melanoma preventation and awareness on 720 ABC Perth.
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.